CSL Ltd (HAM:CSJ)
€ 68.23 +0.050 (+0.07%) Market Cap: 32.84 Bil Enterprise Value: 43.24 Bil PE Ratio: 94.26 PB Ratio: 2.00 GF Score: 73/100

Half Year 2024 CSL Ltd Earnings Presentation Transcript

Feb 13, 2024 / 12:00AM GMT
Release Date Price: €169.15 (-2.37%)

Feb 13, 2024 / 12:00AM GMT
Presentation
Feb 13, 2024 / 12:00AM GMT

=====================
Corporate Participants
=====================
* Andy Schmeltz
CSL Limited - EVP of CSL Behring Business Unit
* Herve Gisserot
Vifor Pharma AG - Chief Commercial Officer
* Joy Carolyn Linton
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul F. McKenzie
CSL Limited - MD, CEO & Executive Director
* Stephen Marlow
CSL Limited - Senior VP & GM of Seqirus
* William Mezzanotte
CSL Limited - Executive VP & Head of Research and Development

=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Financial Services Pty Limited, Research Division - Senior Analyst
* Andrew Paine
CLSA Limited, Research Division - Research Analyst
* Craig Wong-Pan
RBC Capital Markets, Research Division - Director of Equity Research & Equity Research Analyst
* David Bailey
Macquarie Research - Analyst
*

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot